Emily Maria Ploeg (Emily M Ploeg)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 7

Top Venues

Oncoimmunology

Cancers

Cancer research

Journal for immunotherapy of cancer

Universitair Medisch Centrum Groningen

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universitair Medisch Centrum Groningen Jan 10 2019

Netherlands

PhD student :: Surgery

Publications

Isabel Britsch, Anne Paulien van Wijngaarden, Xiurong Ke, Mark Alexander Johannes Martinus Hendriks, Douwe Freerk Samplonius, Emily Maria Ploeg, Wijnand Helfrich
Novel Fab-peptide-HLA-I fusion proteins for redirecting pre-existing anti-CMV T cell immunity to selective eliminate carcinoma cells. Oncoimmunology 12 (1) (2023)
Emily Maria Ploeg, Isabel Britsch, Anne Paulien van Wijngaarden, Xiurong Ke, Mark Alexander Johannes Martinus Hendriks, Douwe Freerk Samplonius, Wijnand Helfrich
A Novel Bispecific Antibody for EpCAM-Directed Inhibition of the CD73/Adenosine Immune Checkpoint in Ovarian Cancer. Cancers 15 (14) (2023)
Emily Maria Ploeg, Douwe Freerk Samplonius, Xiao Xiong, Xiurong Ke, Mark Alexander Johannes Martinus Hendriks, Isabel Britsch, Anne Paulien van Wijngaarden, Hao Zhang, Wijnand Helfrich
Bispecific antibody CD73xEGFR more selectively inhibits the CD73/adenosine immune checkpoint on cancer cells and concurrently counteracts pro-oncogenic activities of CD73 and EGFR. Journal for immunotherapy of cancer 11 (9) (2023)
Isabel Britsch, Anne Paulien van Wijngaarden, Xiurong Ke, Mark Alexander Johannes Martinus Hendriks, Douwe Freerk Samplonius, Emily Maria Ploeg, Wijnand Helfrich
Novel Fab-peptide-HLA-I fusion proteins for redirecting pre-existing anti-CMV T cell immunity to selective eliminate carcinoma cells. Oncoimmunology 12 (1) (2023)
Mark Alexander Johannes Martinus Hendriks, Isabel Britsch, Xiurong Ke, Anne Paulien van Wijngaarden, Douwe Freerk Samplonius, Emily Maria Ploeg, Wijnand Helfrich
Cancer cells under immune attack acquire CD47-mediated adaptive immune resistance independent of the myeloid CD47-SIRPα axis. Oncoimmunology 10 (1) (2021)
Mark Alexander Johannes Martinus Hendriks, Emily Maria Ploeg, Iris Koopmans, Isabel Britsch, Xiurong Ke, Douwe Freerk Samplonius, Wijnand Helfrich
Bispecific antibody approach for EGFR-directed blockade of the CD47-SIRPα "don't eat me" immune checkpoint promotes neutrophil-mediated trogoptosis and enhances antigen cross-presentation. Oncoimmunology 9 (1) (2020)
Paul B M Essers, Martijn van der Heijden, Caroline V M Verhagen, Emily Maria Ploeg, Reinout H de Roest, C René Leemans, Ruud H Brakenhoff, Michiel W M van den Brekel, Harry Bartelink, Marcel Verheij, Conchita Vens
Drug Sensitivity Prediction Models Reveal a Link between DNA Repair Defects and Poor Prognosis in HNSCC. Cancer research 79 (21) (2019)

Emily Maria Ploeg.css-eqlu8i{font-size:small;padding-left:4px;} (Emily M Ploeg)

Publication Activity (10 Years)

Top Topics

Top Venues

Emily Maria Ploeg (Emily M Ploeg)